> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# MR Contour DL Model Cleared for Organ Segmentation
- URL: https://www.fdaweb.com/mr-contour-dl-model-cleared-for-organ-segmentation/
- Published: 2025-05-02T12:00:00.000Z
- Updated: 2026-09-14T15:10:53.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5159110

FDA has cleared a GE HealthCare 510(k) for its MR Contour DL, an artificial intelligence (AI) model that uses deep learning for organs-at-risk (OAR) segmentation. The device “leverages the soft-tissue detail of MR \[magnetic resonance\] images to create precise organ contours of OAR during radiation therapy treatment planning, a process that was previously entirely manual, bringing efficiency, consistency, and accuracy,” the company says. The AI model is capable of segmenting 37 organs and structures in the head, neck and pelvic regions based on standard 2D or 3D MR image datasets, it adds.

GE says the device will be integrated into its updated Intelligent Radiation Therapy solution for radiation therapy workflow management, which enables a complete AI-powered, MR-only simulation workflow to help deliver more precise radiation therapy treatment.